US2772204A - Dental preparations containing higher aliphatic acyl sarcoside compounds - Google Patents

Dental preparations containing higher aliphatic acyl sarcoside compounds Download PDF

Info

Publication number
US2772204A
US2772204A US455761A US45576154A US2772204A US 2772204 A US2772204 A US 2772204A US 455761 A US455761 A US 455761A US 45576154 A US45576154 A US 45576154A US 2772204 A US2772204 A US 2772204A
Authority
US
United States
Prior art keywords
compounds
sarcoside
sodium
dental
aliphatic acyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US455761A
Inventor
King William James
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Colgate Palmolive Co
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Priority to US455761A priority Critical patent/US2772204A/en
Application granted granted Critical
Publication of US2772204A publication Critical patent/US2772204A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/06Chelate

Definitions

  • the present invention relates to dental preparations comprising certain higher aliphatic acyl sarcoside compounds.
  • the instant application is a continuation-in-part of'co-pending applications, Serial No. 258,759 filed November 28, 1951, and Serial No. 271,864 filed February 15, 1952, now U. S. Patent No. 2,689,170 issued September 14, 1954.
  • improved dental preparations may be prepared by the incorporation of a substantially saturated higher aliphatic acyl sarcoside compound containing 17-18 carbons in said acyl group.
  • these active ingredients comprise the stearoyl and heptadecanoyl amides of sarcosine compounds.
  • These compounds may be employed in the form of the free acids or preferably as the Water-soluble salts thereof.
  • Suitable salts are the alkali metal (e. g. sodium and potassium), ammonium, amine and alkylolamine (e. g. mono-, diand triethanolamine) salts and the like.
  • Further specific examples are stearoyl sarcosine and its sodium and potassium salts, and heptadecanoyl sarcosine and its sodium and potassium salts.
  • the terms sarcoside compound or sarcoside refer to such compounds having a free carboxylic group or the watersoluble salts thereof, unless further specified.
  • amide compounds should be utilized in pure or substantially pure form. They should be substantially free from soap or similar higher fatty acid material which is formed in normal commercial methods of manufacture and which tends to neutralize or substantially reduce some of the special characteristics of the active ingredients. In usual practice, the amount of higher fatty acid material should be less than by weight of the amide compound and insuflicient to substantially adversely affect said amide, and preferably less than about 10% of said amide with optimum results at 0-5% fatty acid material. 7 1
  • These compounds may be produced in pure or substantially pure form by the condensation of the corresponding fatty acylating substance, such as stearic acid chloride (or equivalent substantially saturated fatty acid -mixtures consisting essentially of the stearic acid chloride), with sarcosine in an alkaline medium, as described in co-pending application, S. N. 271,864, now U. S..Patent No. 2,689,170.
  • a fatty acylating substance such as stearic acid chloride (or equivalent substantially saturated fatty acid -mixtures consisting essentially of the stearic acid chloride)
  • sarcosine in an alkaline medium
  • the heptadecanoyl acid chloride is condensed with sarcosine (20% molar excess) at a pH of about 10.5 in presence of sodium hydroxide and at room temperature to form the corresponding sodium heptadecanoyl sarcoside.
  • This product is acidified to a pH of 2, extracted with ethyl ether, washed with 5% sulfuric acid and water, and dried.
  • the resulting heptadecanoyl sarcosine beneficial characteristics of particular desirability in is crystallized from Skellysolve E, neutralized with alcoholic sodium hydroxide and re-crystallized from alco-v hol. Analysis of the sodium salt shows that it has a melting point of 143.5-144" C.
  • the heptadecanoyl sarcosine compound has a melting point of 6970 C.
  • the other soluble salts, as indicated above, are formed similarly by neutralization with the desired base, such as potassium hydroxide or ethanolamine to form the corresponding salts.
  • These compounds exhibit many highly unusual and dental preparations. Among the unusual properties is their anti-bacterial power on the oral flora (the complex mixture of micro-organisms normally present in the mouth). These compounds exhibit a superior inhibiting effect on bacterial growth and the production of "acid from fermentable carbohydrates by these micro-organisms found in saliva. This superior inhibiting effect may be illustrated by the Snyder dilution test which is known in the art. In accordance with this test, a very small portion of these compounds may be added to Snyder tubes containing a nutrient dextrose agar with brom-cresol green indicator which had been inoculated previously with saliva.
  • the tubes containing these compounds are still green in color indicating marked inhibition of 'acid production with no evidence of bacterial growth.
  • similar tubes without the addition of these compounds have turned yellow after only 24 hours incubation indicative of rapid and substantial acid formation, with the formation of bacterial colonies.
  • the minimum amount of sodium stearoyl sarcoside which is necessary to maintain a predominantly green color for 72 hours in the Snyder test is an amount corresponding to about 50 milligrams per cc. of the saliva normally turning the control tubes yellow in 24 hours.
  • dental preparations include suitable toothpaste and dental creams, tooth powders, liquid dentifrices, mouth washes or rinses, lozenges, tablets,"chewing gum, dental floss and the like.
  • These preparations may contain various adjuvant materials in suitable amounts provided the same do not substantially adversely afiect the desired results. Any suitable amount of these compounds may be incorporated in the dental preparation.
  • the specific amount will vary, naturally, depending upon the specific type of preparation and the specific effects desired, but will generally be a minor amount of the composition, such as usually at least about 0.05 and up to about 10% by Weight. In the case of dentifrices such as dental creams, it is preferred to use an amount from about 0.25 to about 5% by weight.
  • any suitable practically water-insoluble polishing agent may be admixed with these'active' ingredients in the preprelatively large number of such materials known in the art including, for example, calcium carbonate, dicalcium phosphate; tricalcium phosphate, insoluble sodium metaphosp a a u inum byes-s i s, mag sium c onat andibentonite.
  • ,I-t ispreferred to, use the water-insoluble calcium and magnesium salts, and, more particularly cal cium.:carbonate and/or; a :caiei-um' phosphate.
  • gen- QlfiL-Ihflsfi polishing agents comprise amajor .proportien by weight of thesolid ingredients and aid in cleansing the mouth: l. .7
  • the liquids, and sol-ids should. necessarily be proportioned to form a creamy mass of desired consistency which is veX-trudible from a 7 collapsible aluminum or lead tube.
  • the liquids in the dental .creamwill eomprise chiefly water, glycerine, sorbitol, propylene glycol andrthe like, including suitable' mixtures thereof. .It is usually-advantageous to use a mixture of both water and a humectant or binder such ness even after aging for long periods oftime.
  • stabilizing agents such as the water-soluble inorganic polyphosphate salts; Examples thereof are the alkali metal salts of 'pyrophosphoric, tripol-yphosphorie or tetraphosphoric' acids. 7 Specific materials are tetrasodium pyrophosphate, -,disodiu m ,diacid pyrophosphate,
  • sodium and potassium tripolyphosphate hexasodium .tetraphosphate and sodium henamctaphosphate salts, with the pyrophosphates preferred; Soluble sodium and potassium metaphosphate.maydaeused also.
  • These stabilizing agents may be employed inzanysuitable amount depending upon the specific formulation but will usuallylae .up to 'pre ly t am-018. by w ie o the composition.
  • the pH of the final formulations of the present invention is variable and, therefore, the products may have any suitable pH value in solution compatible with the stability of the materials.
  • pH values it has reference to the pH as determined on'a liquidproduct 'per se, and in the .case of a dental cream or with optimum desired eifects at a' substantially neutral pH value in solution, e. -g., about 6 to 8.
  • a dentifrice comprising a polishing material and a minor amount of sodium N-heptadecanoyl sarcoside hav ing less than about 10% of higher fatty acid material based on the weight of sarcoside.
  • a dentifrice comprising a polishing material and a minor amount of sodium N-stearoyl sarcoside having less than about 10% of higher fatty acid material based on the weight of sarcoside.

Description

United States Patent DENTAL PREPARATIQNS CONTAINING HIGHER ALIPHATIC ACYL SARCOSIDE COMPOUNDS William James King, River Edge, N. assignor to C01- gate-Palmolive Company, Jersey City, N. 3., a corporation of Delaware v No Drawing. Application September 13, 1954,
erial No. 455,761
3 Claims. or. 167- 93) The present invention relates to dental preparations comprising certain higher aliphatic acyl sarcoside compounds. The instant application is a continuation-in-part of'co-pending applications, Serial No. 258,759 filed November 28, 1951, and Serial No. 271,864 filed February 15, 1952, now U. S. Patent No. 2,689,170 issued September 14, 1954.
Many commercial dental preparations have incorporated therein minor amounts of certain detergents such as soap to provide detersive and foaming characteristics.
According to the present invention, improved dental preparations may be prepared by the incorporation of a substantially saturated higher aliphatic acyl sarcoside compound containing 17-18 carbons in said acyl group.
Thus, these active ingredients comprise the stearoyl and heptadecanoyl amides of sarcosine compounds. These compounds may be employed in the form of the free acids or preferably as the Water-soluble salts thereof. Suitable salts are the alkali metal (e. g. sodium and potassium), ammonium, amine and alkylolamine (e. g. mono-, diand triethanolamine) salts and the like. Further specific examples are stearoyl sarcosine and its sodium and potassium salts, and heptadecanoyl sarcosine and its sodium and potassium salts. For convenience, herein, the terms sarcoside compound or sarcoside refer to such compounds having a free carboxylic group or the watersoluble salts thereof, unless further specified.
These amide compounds should be utilized in pure or substantially pure form. They should be substantially free from soap or similar higher fatty acid material which is formed in normal commercial methods of manufacture and which tends to neutralize or substantially reduce some of the special characteristics of the active ingredients. In usual practice, the amount of higher fatty acid material should be less than by weight of the amide compound and insuflicient to substantially adversely affect said amide, and preferably less than about 10% of said amide with optimum results at 0-5% fatty acid material. 7 1
These compounds may be produced in pure or substantially pure form by the condensation of the corresponding fatty acylating substance, such as stearic acid chloride (or equivalent substantially saturated fatty acid -mixtures consisting essentially of the stearic acid chloride), with sarcosine in an alkaline medium, as described in co-pending application, S. N. 271,864, now U. S..Patent No. 2,689,170. -It is believed that the heptadecanoyl sarcoside compounds are specifically novel, and therefore the process will be illustrated with particular reference thereto. Normal heptadecanoic acid is treated with phosphorus trichloride to obtain the corresponding acid chloride. The heptadecanoyl acid chloride is condensed with sarcosine (20% molar excess) at a pH of about 10.5 in presence of sodium hydroxide and at room temperature to form the corresponding sodium heptadecanoyl sarcoside. This product is acidified to a pH of 2, extracted with ethyl ether, washed with 5% sulfuric acid and water, and dried. The resulting heptadecanoyl sarcosine beneficial characteristics of particular desirability in is crystallized from Skellysolve E, neutralized with alcoholic sodium hydroxide and re-crystallized from alco-v hol. Analysis of the sodium salt shows that it has a melting point of 143.5-144" C. and a neutral equivalent of 344 with less than 1% soap content. The heptadecanoyl sarcosine compound has a melting point of 6970 C. The other soluble salts, as indicated above, are formed similarly by neutralization with the desired base, such as potassium hydroxide or ethanolamine to form the corresponding salts.
These compounds exhibit many highly unusual and dental preparations. Among the unusual properties is their anti-bacterial power on the oral flora (the complex mixture of micro-organisms normally present in the mouth). These compounds exhibit a superior inhibiting effect on bacterial growth and the production of "acid from fermentable carbohydrates by these micro-organisms found in saliva. This superior inhibiting effect may be illustrated by the Snyder dilution test which is known in the art. In accordance with this test, a very small portion of these compounds may be added to Snyder tubes containing a nutrient dextrose agar with brom-cresol green indicator which had been inoculated previously with saliva. After 72 hours incubation at 37 C., the tubes containing these compounds are still green in color indicating marked inhibition of 'acid production with no evidence of bacterial growth. As a control, similar tubes without the addition of these compounds have turned yellow after only 24 hours incubation indicative of rapid and substantial acid formation, with the formation of bacterial colonies. For example, the minimum amount of sodium stearoyl sarcoside which is necessary to maintain a predominantly green color for 72 hours in the Snyder test is an amount corresponding to about 50 milligrams per cc. of the saliva normally turning the control tubes yellow in 24 hours. As indicative of the specificity of action with respect to the chemical structure of these active ingredients, it has been found that such structurally-similar materials as sodium stearoyl glycide and sodium oleyl sarcoside are not equivalents but are markedly inferior in anti-bacterial activity against the oral flora and inhibition of acid formation.
It has been found also that these active ingredients have the property of reducing the solubility of tooth enamel in acid to a marked degree. Such laboratory tests for evaluating the reductionin enamel solubility are known. Data obtained in such tests indicate that both sodium stearoyl and heptadecanoyl sarcosides exhibit significant effects in this respect whereas unsaturated compounds such as sodium oleyl and elaidyl sarcosides are markedly inferior.
These active ingredients may be utilized in any preparation designed for application to the oral cavity which are referred to herein as dental preparations. Such dental preparations include suitable toothpaste and dental creams, tooth powders, liquid dentifrices, mouth washes or rinses, lozenges, tablets,"chewing gum, dental floss and the like. These preparations may contain various adjuvant materials in suitable amounts provided the same do not substantially adversely afiect the desired results. Any suitable amount of these compounds may be incorporated in the dental preparation. The specific amount will vary, naturally, depending upon the specific type of preparation and the specific effects desired, but will generally be a minor amount of the composition, such as usually at least about 0.05 and up to about 10% by Weight. In the case of dentifrices such as dental creams, it is preferred to use an amount from about 0.25 to about 5% by weight.
Any suitable practically water-insoluble polishing agent may be admixed with these'active' ingredients in the preprelatively large number of such materials known in the art including, for example, calcium carbonate, dicalcium phosphate; tricalcium phosphate, insoluble sodium metaphosp a a u inum byes-s i s, mag sium c onat andibentonite. ,I-t ispreferred to, use the water-insoluble calcium and magnesium salts, and, more particularly cal cium.:carbonate and/or; a :caiei-um' phosphate. In gen- QlfiL-Ihflsfi polishing agents comprise amajor .proportien by weight of thesolid ingredients and aid in cleansing the mouth: l. .7
In h p e a -Q eq e dei it s svf ficient to mechanically admin the Mar -ious' ingredients.
In dental cream formulations, the liquids, and sol-ids should. necessarily be proportioned to form a creamy mass of desired consistency which is veX-trudible from a 7 collapsible aluminum or lead tube. In general, the liquids in the dental .creamwill eomprise chiefly water, glycerine, sorbitol, propylene glycol andrthe like, including suitable' mixtures thereof. .It is usually-advantageous to use a mixture of both water and a humectant or binder such ness even after aging for long periods oftime. l Various suitable stabilizing agentsare-calcium andmagnesium sequestering agents such as the water-soluble inorganic polyphosphate salts; Examples thereof are the alkali metal salts of 'pyrophosphoric, tripol-yphosphorie or tetraphosphoric' acids. 7 Specific materials are tetrasodium pyrophosphate, -,disodiu m ,diacid pyrophosphate,
sodium and potassium tripolyphosphate, hexasodium .tetraphosphate and sodium henamctaphosphate salts, with the pyrophosphates preferred; Soluble sodium and potassium metaphosphate.maydaeused also. Other suitalkali metal and preferably-sodium salts. of ethylene diamine tetraacetic :acid and'citric acid. These stabilizing agents may be employed inzanysuitable amount depending upon the specific formulation but will usuallylae .up to 'pre ly t am-018. by w ie o the composition.
aration of various. dentifice compositions. There is a 7 able stabilizing agents are .ch la i lg a n s h as the Other adjuyant materials are usually incorporated in 7 7 may vary depending on the mouth effect desired, such weight; Liguiddentifrices are also included, such produ t ellc ntain n dd tio m i agin9u m terial ;and ioptionall y combined with small amounts of 7 reli i as sigly r nc andit e like- An her bodiment is hewing su whi h wi l con ain :mi QIj I-u efiective amounts of these active ingredients incorp:orated in t e s m a e such as ch .QI o her natural or sy thetic rubber and gum-like materials.
Sodium stearoyl-sarcosidei;
The pH of the final formulations of the present invention is variable and, therefore, the products may have any suitable pH value in solution compatible with the stability of the materials. Where reference is made to pH values it has reference to the pH as determined on'a liquidproduct 'per se, and in the .case of a dental cream or with optimum desired eifects at a' substantially neutral pH value in solution, e. -g., about 6 to 8.
The following specific examples are further illustrative" of the nature of the present invention, but it is to be understood that the invention is notlimited thereto. The
preparations may be prepared in the'usual manner and all amounts of the various ingredients are by Weightunless otherwise specified. I V V W Example'l Dntal c eam 7 Percent the balance consisting essentially of soluble saccharin,
flavor and preservatives.
hExai rtple'llir-efoo th powder 7 1 V Percent 'Sodiumpheptadecandly sarcosi'de 3.0 Calcium carbonate a 25:0 Dicalcium phosphate..dihydrate "70.0 Saccharin, soluble L.. a;;n; '0i2 Flavor'n V "128 77 7 100.0 Examplelllsa-Mouth wash 7 77 V V Percent Potassium stearoyl sarcoside; -O .1-;'0.2 Ethyl alcohol V i i i 7' i "10.0 Flavor V 7 w 7 V 0:15 'Saccharin, soluble a (X0 1. Distilled water Q ;Q -L Balance Example IV. Che.wing g um 7 1 rcen .Sodium .stearqyl, arc s 0.5 Gum base, e. g. ch c 7, 20.1) Sucrose 60.0 Corn syrup", 1 8.5 Flavor 3139 7 7 7 7 V 5 109.0 Example :V.-+Liquid dantirifice V 7 7 7 7 7 7 7 Percent Sodium .stearoyl sarcoside' 2.0 :Sodium ,carbonymethylCellulose..- 2:0 Flavor 0.5 Distilled wat r Balance .Although the present invention been described reference :to particular embodiments and examples, it' I will be apparent to those skilled in that Yart that. lvaria lions a m difis as 9 th s n entis n e made sl thateguivalents can be substituted therefor without parting ,from the principles and true spirit of in- ,Ha ng' us' ;d isd th was. w i .clai ed is. l i v V .i A en a Pre a ion a mnp i s a ar q ds pound selected from the group consisting of N-heptadecanoyl and N-strearoyl sarcoside compounds having less than about 15% based on the weight of said satcoside of higher fatty acid material, the amount of said material being insufiicient to adversely afiect said sarcoside.
2. A dentifrice comprising a polishing material and a minor amount of sodium N-heptadecanoyl sarcoside hav ing less than about 10% of higher fatty acid material based on the weight of sarcoside.
3. A dentifrice comprising a polishing material and a minor amount of sodium N-stearoyl sarcoside having less than about 10% of higher fatty acid material based on the weight of sarcoside.
References Cited in the file of this patent UNITED STATES PATENTS Dreyfus Dec. 15, 1936 Bird Oct. 25, 1949 King Sept. 14, 1954 FOREIGN PATENTS Germany Sept. 18, 1936 Germany Apr. 27, 1939 Great Britain Nov. 3, 1936 Great Britain Dec. 28, 1936 Great Britain Feb. 15, 1937 France July 6, 1935 France Dec. 26, 1935

Claims (1)

1. A DENTAL PERPARATION COMPRISING A SARCOSIDE COMPOUND SELECTED FROM THE GROUP CONSISTING OF N-HEPTADECANOYL AND N-STREAROYL SACOSIDE COMPOUNDS HAVING LESS THAN ABOUT 15% BASED ON THE WEIGHT OF SAID SARCOSIDE OF HIGHER FATTY ACID MATERIAL, THE AMOUNT OF SAID MATERIAL BEING INSUFFICIENT TO ADVERSELY AFFECT SAID SARCOSIDE.
US455761A 1954-09-13 1954-09-13 Dental preparations containing higher aliphatic acyl sarcoside compounds Expired - Lifetime US2772204A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US455761A US2772204A (en) 1954-09-13 1954-09-13 Dental preparations containing higher aliphatic acyl sarcoside compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US455761A US2772204A (en) 1954-09-13 1954-09-13 Dental preparations containing higher aliphatic acyl sarcoside compounds

Publications (1)

Publication Number Publication Date
US2772204A true US2772204A (en) 1956-11-27

Family

ID=23810179

Family Applications (1)

Application Number Title Priority Date Filing Date
US455761A Expired - Lifetime US2772204A (en) 1954-09-13 1954-09-13 Dental preparations containing higher aliphatic acyl sarcoside compounds

Country Status (1)

Country Link
US (1) US2772204A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932603A (en) * 1971-05-28 1976-01-13 General Foods Corporation Oral preparations for reducing the incidence of dental caries
US4088752A (en) * 1974-05-31 1978-05-09 Gaba Ag Oral composition for plaque and caries inhibition
US4122162A (en) * 1974-05-31 1978-10-24 Muehlemann Hans R Oral composition for plaque and caries inhibition
US4545979A (en) * 1982-02-22 1985-10-08 Warner-Lambert Company Dental hygiene compositions
US4550018A (en) * 1984-02-22 1985-10-29 Warner-Lambert Company Dental hygiene compositions
US5017364A (en) * 1988-10-20 1991-05-21 Ajinomoto Co., Inc. Paste-like dentifrice composition
US5266306A (en) * 1990-05-29 1993-11-30 Sunstar Kabushiki Kaisha Oral composition

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR787819A (en) * 1934-03-24 1935-09-30 Ig Farbenindustrie Ag New washing and cleaning agents
FR795052A (en) * 1934-09-20 1936-03-03 Gruenau Landshoff Chem Fab Cosmetic products
DE635522C (en) * 1930-05-16 1936-09-18 Ig Farbenindustrie Ag Detergents, wetting agents, dispersants and leveling agents
GB456142A (en) * 1934-05-04 1936-11-03 Ig Farbenindustrie Ag Improvements relating to assistants for use in the textile, leather, paper and like industries
US2063987A (en) * 1931-09-18 1936-12-15 Dreyfus Henry Amino carboxylic acid condensation products and process of making them
GB459039A (en) * 1934-03-24 1936-12-28 Ig Farbenindustrie Ag Manufacture of washing agents and detergents
GB461328A (en) * 1934-08-14 1937-02-15 Ig Farbenindustrie Ag Improvements in washing and cleansing
DE675837C (en) * 1932-06-12 1939-05-22 Ig Farbenindustrie Ag Dentifrices
US2486249A (en) * 1947-07-19 1949-10-25 Nat Aluminate Corp Acylamino-nu-substituted amides
US2689170A (en) * 1952-02-15 1954-09-14 Colgate Palmolive Co Oral preparation for inhibition of dental caries

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE635522C (en) * 1930-05-16 1936-09-18 Ig Farbenindustrie Ag Detergents, wetting agents, dispersants and leveling agents
US2063987A (en) * 1931-09-18 1936-12-15 Dreyfus Henry Amino carboxylic acid condensation products and process of making them
DE675837C (en) * 1932-06-12 1939-05-22 Ig Farbenindustrie Ag Dentifrices
FR787819A (en) * 1934-03-24 1935-09-30 Ig Farbenindustrie Ag New washing and cleaning agents
GB459039A (en) * 1934-03-24 1936-12-28 Ig Farbenindustrie Ag Manufacture of washing agents and detergents
GB456142A (en) * 1934-05-04 1936-11-03 Ig Farbenindustrie Ag Improvements relating to assistants for use in the textile, leather, paper and like industries
GB461328A (en) * 1934-08-14 1937-02-15 Ig Farbenindustrie Ag Improvements in washing and cleansing
FR795052A (en) * 1934-09-20 1936-03-03 Gruenau Landshoff Chem Fab Cosmetic products
US2486249A (en) * 1947-07-19 1949-10-25 Nat Aluminate Corp Acylamino-nu-substituted amides
US2689170A (en) * 1952-02-15 1954-09-14 Colgate Palmolive Co Oral preparation for inhibition of dental caries

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932603A (en) * 1971-05-28 1976-01-13 General Foods Corporation Oral preparations for reducing the incidence of dental caries
US4088752A (en) * 1974-05-31 1978-05-09 Gaba Ag Oral composition for plaque and caries inhibition
US4122162A (en) * 1974-05-31 1978-10-24 Muehlemann Hans R Oral composition for plaque and caries inhibition
US4545979A (en) * 1982-02-22 1985-10-08 Warner-Lambert Company Dental hygiene compositions
US4550018A (en) * 1984-02-22 1985-10-29 Warner-Lambert Company Dental hygiene compositions
US5017364A (en) * 1988-10-20 1991-05-21 Ajinomoto Co., Inc. Paste-like dentifrice composition
US5266306A (en) * 1990-05-29 1993-11-30 Sunstar Kabushiki Kaisha Oral composition

Similar Documents

Publication Publication Date Title
US4465662A (en) Oral compositions of tranexamic acid and carvone
US3137632A (en) Chlorophyll dentifrice compositions
US2689170A (en) Oral preparation for inhibition of dental caries
US4244931A (en) Dicalcium phosphate dihydrate with improved stability
EP0297212B1 (en) Oral compositions
US2757125A (en) N-higher alkyl-4-carboxy-2-pyrrolidones and compositions therewith
US4247526A (en) Method for preparing dicalcium phosphate dihydrate with improved stability
US3531564A (en) Fluoride dental preparation
US2772203A (en) Stable dental creams containing higher aliphatic acyl amide of aminocarboxxylic acid compound
EP0256566B1 (en) Use of usnic acid or derivatives thereof in the treatment of dental caries
EP0236290A1 (en) Anticalculus dentifrices
US3029191A (en) Dental preparations consisting essentially of a fluoride compound and a sarcoside compound to reduce the fluoride toxicity
US2501145A (en) Composition for release of oxygen
US2772204A (en) Dental preparations containing higher aliphatic acyl sarcoside compounds
US2829086A (en) Dental preparations comprising higher aliphatic perfluorinated acid compounds
US2955985A (en) Dentifrice compositions
US3968263A (en) Beverage mix and method
EP0191561B1 (en) Anticariogenic or antiperiodontitic agent
JPH0140005B2 (en)
US3427381A (en) Oral compositions for retarding dental plaque formation comprising benzohydroxamic acid
US4431630A (en) Dentifrice composition
US3034967A (en) Fluoride dentifrice with insoluble alkali metal metaphosphate and aluminum compound polishing material
KR880002221B1 (en) Oral composition
GB2073019A (en) Oral compositions containing tranexamic acid
KR870009707A (en) Dicalcium phosphate dihydrate composition for fluorinated dentifrice and preparation method thereof and toothpaste containing same